Aavis Pharmaceuticals

About Aavis Pharmaceuticals

Aavis Pharmaceuticals - Touching Lives by Reinventing Healthcare is a USFDA approved, privately owned and one of the fastest growing pharmaceutical company based out of Atlanta Region, USA. Company is engaged in Contract Development and Manufacturing of Generic Pharmaceuticals. We develop niche generic drugs with a expertise in development, including advanced scientific research, process development, patent analysis, regulatory compliance and market & competition analysis. Aavis is looking to be market leader in the generic developed by them with continuous improvement in manufacturing process, technology and possible vertical integration. Aavis is a part of Espee Group. Globally Renowned Pharmaceutical Conglomerate. Espee Group strives to be a single point contact for large scale developed pharmaceutical manufacturers across the world for their product development to contract manufacturing to distribution requirements. Espee Group focuses on building partnership and relations to enhance the business growth. Thus relations at Espee Group are v...

  • US
  • 2017
    On CPHI since
Contact info

Products from Aavis Pharmaceuticals (3)

  • Chrono release system service

    Product Chrono release system service

    Aavis pharmaceuticals offers a formulation development service which includes chrono release system. It enables a drug to be released such that its effect takes advantage of the circadian rhythms of the human body. Contact us for more information.
  • Contract manufacturing service

    Product Contract manufacturing service

    Aavis pharmaceuticals offers contract manufacturing service. It is a cgmp certified company with facilities to manufacture and pack a wide variety of dosage forms for commercial manufacturing. Contact us for more information.
  • Contract research service

    Product Contract research service

    Aavis pharmaceuticals offers contract research service. It research to develop new formulations for existing products to potentially enhance therapeutic efficiency as well as to new drug molecules to improve patient compliance. Contact us for more information.